Induction of cyclooxygenase-2 by ginsenoside Rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 51-56

  Jeong, Hye Gwang ^a   Pokharel, Yuba Raj ^a   Han, Eun Hee ^a   Kang, Keon Wook ^a  

^a Chosun University   (South Korea)

Author keywords

C EBP; COX 2; CREB; Ginsenoside Rd

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; DNA; GINSENOSIDE RB 1; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; LUCIFERASE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GEL; GENE ACTIVATION; GENE CONTROL; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; WESTERN BLOTTING;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; MACROPHAGES; MICE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

PANAX GINSENG;

EID: 34249736955     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.034     Document Type: Article

References (38)

1. Cheng Y., Shen L.H., and Zhang J.T. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol. Sin. 26 (2005) 143-149
2. Lee T.K., Johnke R.M., Allison R.R., O'Brien K.F., and Dobbs Jr. L.J. Radioprotective potential of ginseng. Mutagenesis 20 (2005) 237-243
3. Yang Z.G., Sun H.X., and Ye Y.P. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem. Biodivers. 3 (2006) 187-197
4. Yang Z., Chen A., Sun H.X., Ye Y.P., and Fang W.H. Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine 25 (2007) 161-169
5. 2+ channels in vascular smooth muscle cells. Eur. J. Pharmacol. 548 (2006) 129-136
6. Goetzl E.J., An S., and Smith W.L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9 (1995) 1051-1058
7. Hla T., and Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 89 (1992) 7384-7388
8. Arias-Negrete S., Keller K., and Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem. Biophys. Res. Commun. 208 (1995) 582-589
9. Tsuji S., Tsujii M., Kawano S., and Hori M. Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. J. Exp. Clin. Cancer Res. 20 (2001) 117-129
10. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takahashi E., and Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. 221 (1994) 889-897
11. Kim Y., and Fischer S.M. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J. Biol. Chem. 273 (1998) 27686-27694
12. Tang Q., Chen W., Gonzales M.S., Finch J., Inoue H., and Bowden G.T. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes. Oncogene 20 (2001) 5164-5172
13. Wu D., Marko M., Claycombe K., Paulson K.E., and Meydani S.N. Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity. J. Biol. Chem. 278 (2003) 10983-10992
14. Yang J.W., Yoon S.Y., Oh S.J., Kim S.K., and Kang K.W. Bifunctional effects of fucoidan on the expression of inducible nitric oxide synthase. Biochem. Biophys. Res. Commun. 346 (2006) 345-350
15. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., and Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem. Biophys. Res. Commun. 237 (1997) 28-32
16. Diaz-Guerra M.J., Velasco M., Martin-Sanz P., and Bosca L. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters. J. Biol. Chem. 271 (1996) 30114-30120
17. Thomas B., Berenbaum F., Humbert L., Bian H., Bereziat G., Crofford L., and Olivier J.L. Critical role of C/EBP-beta and C/EBP-delta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1 in articular chondrocytes. Eur. J. Biochem. 267 (2000) 6798-6809
18. Tamura M., Sebastian S., Yang S., Gurates B., Fang Z., Okamura K., and Bulun S.E. Induction of cyclooxygenase-2 in human endometrial stromal cells by malignant endometrial epithelial cells: evidence for the involvement of extracellularly regulated kinases and CCAAT/enhancer binding proteins. J. Mol. Endocrinol. 31 (2003) 95-104
19. Hofseth L.J., and Wargovich M.J. Inflammation, cancer, and targets of ginseng. J. Nutr. 137 (2007) 183S-185S
20. Andrew P.J., Harant H., and Lindley I.J. Up-regulation of interleukin-1beta-stimulated interleukin-8 in human keratinocytes by nitric oxide. Biochem. Pharmacol. 57 (1999) 1423-1429
21. Friedl R., Moeslinger T., Kopp B., and Spieckermann P.G. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells. Br. J. Pharmacol. 134 (2001) 1663-1670
22. Kim N.D., Kim E.M., Kang K.W., Cho M.K., Choi S.Y., and Kim S.G. Ginsenoside Rg3 inhibits phenylephrine- induced vascular contraction through induction of nitric oxide synthase. Br. J. Pharmacol. 140 (2003) 661-670
23. Wu C.F., Bi X.L., Yang J.Y., Zhan J.Y., Dong Y.X., Wang J.H., Wang J.M., Zhang R., and Li X. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int. Immunopharmacol. 7 (2007) 313-320
24. Park E.K., Shin Y.W., Lee H.U., Kim S.S., Lee Y.C., Lee B.Y., and Kim D.H. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28 (2005) 652-656
25. Bae E.A., Kim E.J., Park J.S., Kim H.S., Ryu J.H., and Kim D.H. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med. 72 (2006) 627-633
26. Park W., Lim W., Cho J., Inoue H., Rhyu M.R., and Lee Y. Inhibitory effects of ginsenoside-Rb1 on activation of the 12-O-tetradecanoylphorbol 13-acetate-induced cyclooxygenase-2 promoter. Planta Med. 72 (2006) 272-275
27. Wardlaw S.A., Zhang N., and Belinsky S.A. Transcriptional regulation of basal cyclooxygenase-2 expression in murine lung tumor-derived cell lines by CCAAT/enhancer-binding protein and activating transcription factor/cAMP response element-binding protein. Mol. Pharmacol. 62 (2002) 326-333
28. Ohshima H., Tatemichi M., and Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417 (2003) 3-11
29. Farrow B., and Evers B.M. Inflammation and the development of pancreatic cancer. Surg. Oncol. 10 (2002) 153-169
30. Lala P.K., and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2 (2001) 149-156
31. Zha S., Yegnasubramanian V., Nelson W.G., Isaacs W.B., and De Marzo A.M. Cyclooxygenases in cancer: progress and perspective. Cancer Lett. 215 (2004) 1-20
32. van Rees B.P., Saukkonen K., Ristimaki A., Polkowski W., Tytgat G.N., Drillenburg P., and Offerhaus G.J. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196 (2002) 171-179
33. Subbaramaiah K., Hart J.C., Norton L., and Dannenberg A.J. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38-mitogen-activated protein kinase pathways. J. Biol. Chem. 275 (2000) 14838-14845
34. Hsueh C.T., Chiu C.F., Kelsen D.P., and Schwartz G.K. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis. Cancer Chemother. Pharmacol. 45 (2000) 389-396
35. Yim H.W., Jong H.S., Kim T.Y., Choi H.H., Kim S.G., Song S.H., Kim J., Ko S.G., Lee J.W., Kim T.Y., and Bang Y.J. Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis. Cancer Res. 65 (2005) 1952-1960
36. Yun T.K. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat. Res. 63-74 (2003) 523-524
37. Kim S.E., Lee Y.H., Park J.H., and Lee S.K. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21WAF1 in human hepatoma SK-HEP-1 cells. Eur. J. Cancer. 35 (1999) 507-511
38. Fei X.F., Wang B.X., Tashiro S., Li T.J., Ma J.S., and Ikejima T. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol. Sin. 23 (2002) 315-322